SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Micrologix biotech -- Ignore unavailable to you. Want to Upgrade?

To: Pete who wrote (435)2/23/1999 12:44:00 PM
From: Biotechboy13  Read Replies (2) | Respond to of 792
 
Pete,

Read carefully stupid....three confirmed cases...not new cases...previously reported. stop dealing the drugs!!!

regards,



To: Pete who wrote (435)2/23/1999 10:04:00 PM
From: Carter Berezay  Respond to of 792
 
Pete, fascinating article. It describes VRE which is almost unstoppable and now it has spread to Staph. aureus which many scientists feared. The woman in Hong Kong died of blood poisoning which is what the new Phase I drug is being tested for.

I do hope MBI 226 works as well as they think it does. If vancomycin is beaten maybe 226 will take over as the "superbug" killer of choice.

Carter B.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News